hematoma Clinical Trials

48 recruitingLast updated: July 25, 2026

There are 48 actively recruiting hematoma clinical trials across 26 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4. Top locations include Boston, Massachusetts, United States, Philadelphia, Pennsylvania, United States, Shanghai, Shanghai Municipality, China. Updated daily from ClinicalTrials.gov.


hematoma Trials at a Glance

48 actively recruiting trials for hematoma are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Not Applicable with 27 trials, with the heaviest enrollment activity in Boston, Philadelphia, and Shanghai. Lead sponsors running hematoma studies include Beijing Tiantan Hospital, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), and Ohio State University.

Browse hematoma trials by phase

Treatments under study

About hematoma Clinical Trials

Looking for clinical trials for hematoma? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new hematoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about hematoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 48 trials

Recruiting
Phase 2Phase 3

Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)

Chronic Subdural Hematoma
St. Olavs Hospital274 enrolled1 locationNCT07245264
Recruiting
Not Applicable

Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma

Chronic Subdural HematomaEndovascular Treatment
Kazutaka Uchida600 enrolled1 locationNCT06772740
Recruiting
Not Applicable

Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas

Chronic Subdural Hematoma
Lahey Clinic400 enrolled1 locationNCT07715656
Recruiting

Al Prediction of Sarcopenia Risk in Neurocritical ICU Patients

Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, Epidural Hematoma, Ischemic Stroke, Brain Neoplasms
Trabzon Kanuni Education and Research Hospital100 enrolled1 locationNCT07712198
Recruiting
Not Applicable

Efficacy of a Minimally Invasive Therapy Adjuvant to the Standards of Care by Cyanoacrylate Embolization

Chronic Subdural Hematoma
University Hospital, Brest550 enrolled11 locationsNCT05374681
Recruiting

European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™

Aneurysm of Aorta, ThoracicDissection of Thoracic AortaDissection of Thoracic Descending Aorta+3 more
Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd100 enrolled4 locationsNCT07668687
Recruiting

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

Aneurysm ThoracicVascular DiseaseDissection+5 more
W.L.Gore & Associates1,500 enrolled36 locationsNCT06658730
Recruiting
Not Applicable

Non-Thermal Plasma to Reduce Recurrence in Chronic Subdural Hematoma

Postoperative ComplicationsRecurrenceSubdural Hematoma+1 more
Benjamín Gonzalo Rodríguez Méndez40 enrolled1 locationNCT07656818
Recruiting
Phase 2

Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy

Postoperative HematomaPostoperative Seroma
University of California, San Francisco150 enrolled1 locationNCT05794321
Recruiting
Phase 3

The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma

Subdural Hematoma
Unity Health Toronto130 enrolled1 locationNCT05713630
Recruiting
Not Applicable

Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study

Chronic Subdural Hematoma
The University of Texas Medical Branch, Galveston520 enrolled31 locationsNCT06347796
Recruiting
Not Applicable

The Effectiveness and Safety of Body Posture in Preventing Postoperative Recurrence for Chronic Subdural Hematoma

RecurrenceChronic Subdural Hematoma
Huashan Hospital830 enrolled1 locationNCT06401772
Recruiting
Phase 2Phase 3

Prospective Clinical Investigation on Infection as a Cause of Chronic Subdural Hematoma.

Chronic Subdural Hematomas
University of Rostock164 enrolled1 locationNCT07556991
Recruiting

Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) (HARMONY)

Subdural HematomaSubdural Hematoma, Chronic
Aesculap AG178 enrolled7 locationsNCT07258069
Recruiting

Ultrasound for Assessment of Intra-Abdominal Blood Loss After Gynecological Surgery

Post-Operative Hematoma at Operative Site (Diagnosis)Post-Operative Hemorrhage
Holy Family Hospital, Nazareth, Israel250 enrolled1 locationNCT06953141
Recruiting

Neurosurgical Outcome Network

DepressionTrigeminal NeuralgiaObsessive-Compulsive Disorder+20 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta4,500 enrolled27 locationsNCT06724029
Recruiting
Not Applicable

Middle Meningeal Artery Embolization for Chronic Subdural Hematomas (STORMM)

Chronic Subdural HematomasCerebral Compression Due to Injury
University Hospital, Geneva180 enrolled2 locationsNCT06163547
Recruiting

Implementation of an Enhanced Recovery Pathway for Burr-hole Drainage in Patients With a Chronic Subdural Hematoma

Chronic Subdural HematomaChronic Subdural Hematomas
Universitaire Ziekenhuizen KU Leuven150 enrolled1 locationNCT07421453
Recruiting
Not Applicable

A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke: Large Basal Ganglia Hemorrhage

Hematoma BrainLarge Basal Ganglia Hemorrhage
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School198 enrolled1 locationNCT06484374
Recruiting
Not Applicable

Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma

Chronic Subdural Hematoma
Beijing Tiantan Hospital770 enrolled24 locationsNCT07144423